Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment

Clin Infect Dis. 2009 May 1;48(9):1318-22. doi: 10.1086/597779.

Abstract

A cross-sectional study, performed at a routine human immunodeficiency virus (HIV)/AIDS clinic in Cameroon that uses the World Health Organization public health approach, showed low rates of virological failure and drug resistance at 12 and 24 months after initiation of antiretroviral therapy. Importantly, the cross-sectional study also showed that the World Health Organization recommendation for second-line treatment would be effective in almost all patients with HIV drug resistance mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use*
  • Cameroon
  • Cross-Sectional Studies
  • Drug Resistance, Viral*
  • Female
  • Guideline Adherence
  • HIV / drug effects*
  • HIV / isolation & purification
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Anti-HIV Agents